Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases

被引:353
作者
Raught, B
Peiretti, F
Gingras, AC
Livingstone, M
Shahbazian, D
Mayeur, GL
Polakiewicz, RD
Sonenberg, N
Hershey, JWB
机构
[1] Univ Calif Davis, Sch Med, Dept Biol Chem, Davis, CA 95616 USA
[2] McGill Univ, Dept Biochem, Montreal, PQ, Canada
[3] McGill Univ, McGill Canc Ctr, Montreal, PQ, Canada
[4] Cell Signaling Technol Inc, Beverly, MA USA
关键词
eIF4B; phosphorylation; S6K; signaling; translation;
D O I
10.1038/sj.emboj.7600193
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The eucaryotic translation initiation factor 4B (eIF4B) stimulates the helicase activity of the DEAD box protein eIF4A to unwind inhibitory secondary structure in the 50 untranslated region of eucaryotic mRNAs. Here, using phosphopeptide mapping and a phosphospecific antiserum, we identify a serum-responsive eIF4B phosphorylation site, Ser422, located in an RNA-binding region required for eIF4A helicase-promoting activity. Ser422 phosphorylation appears to be regulated by the S6Ks: (a) Ser422 phosphorylation is sensitive to pharmacological inhibitors of phosphoinositide-3 kinase and the mammalian target of rapamycin; (b) S6K1/S6K2 specifically phosphorylate Ser422 in vitro; and (c) rapamycin-resistant S6Ks confer rapamycin resistance upon Ser422 phosphorylation in vivo. Substitution of Ser422 with Ala results in a loss of activity in an in vivo translation assay, indicating that phosphorylation of this site plays an important role in eIF4B function. We therefore propose that eIF4B may mediate some of the effects of the S6Ks on translation.
引用
收藏
页码:1761 / 1769
页数:9
相关论文
共 55 条
[1]   A SACCHAROMYCES-CEREVISIAE HOMOLOG OF MAMMALIAN TRANSLATION INITIATION FACTOR-4B CONTRIBUTES TO RNA HELICASE ACTIVITY [J].
ALTMANN, M ;
MULLER, PP ;
WITTMER, B ;
RUCHTI, F ;
LANKER, S ;
TRACHSEL, H .
EMBO JOURNAL, 1993, 12 (10) :3997-4003
[2]   Orally administered leucine stimulates protein synthesis in skeletal muscle of postabsorptive rats in association with increased elF4F formation [J].
Anthony, JC ;
Anthony, TG ;
Kimball, SR ;
Vary, TC ;
Jefferson, LS .
JOURNAL OF NUTRITION, 2000, 130 (02) :139-145
[3]  
Barbe Esther, 1996, MEDITERR POLIT, V1, P25
[4]  
BENNE R, 1978, J BIOL CHEM, V253, P3078
[5]   Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002 [J].
Brunn, GJ ;
Williams, J ;
Sabers, C ;
Wiederrecht, G ;
Lawrence, JC ;
Abraham, RT .
EMBO JOURNAL, 1996, 15 (19) :5256-5267
[6]   The phosphoinositide 3-kinase pathway [J].
Cantley, LC .
SCIENCE, 2002, 296 (5573) :1655-1657
[7]   STRUCTURAL AND FUNCTIONAL-ANALYSIS OF PP70(S6K) [J].
CHEATHAM, L ;
MONFAR, M ;
CHOU, MM ;
BLENIS, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (25) :11696-11700
[8]   RAPAMYCIN FKBP SPECIFICALLY BLOCKS GROWTH-DEPENDENT ACTIVATION OF AND SIGNALING BY THE 70 KD S6 PROTEIN-KINASES [J].
CHUNG, J ;
KUO, CJ ;
CRABTREE, GR ;
BLENIS, J .
CELL, 1992, 69 (07) :1227-1236
[9]   Phosphorylation sites in the autoinhibitory domain participate in p70s6k activation loop phosphorylation [J].
Dennis, PB ;
Pullen, N ;
Pearson, RB ;
Kozma, SC ;
Thomas, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (24) :14845-14852
[10]   Target of rapamycin [J].
Dennis, PB ;
Thomas, G .
CURRENT BIOLOGY, 2002, 12 (08) :R269-R269